SubHero Banner
Text

Abilify MyCite® (aripiprazole tablets with sensor) – New drug approval

November 13, 2017 – The FDA announced the approval of Otsuka and Proteus’ Abilify MyCite (aripiprazole tablets with sensor), a drug-device combination product comprised of oral aripiprazole tablets embedded with an ingestible event marker (IEM) sensor.

Download PDF